PMID- 24694926 OWN - NLM STAT- MEDLINE DCOM- 20150415 LR - 20211021 IS - 1740-634X (Electronic) IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 39 IP - 10 DP - 2014 Sep TI - A window into the intoxicated mind? Speech as an index of psychoactive drug effects. PG - 2340-8 LID - 10.1038/npp.2014.80 [doi] AB - Abused drugs can profoundly alter mental states in ways that may motivate drug use. These effects are usually assessed with self-report, an approach that is vulnerable to biases. Analyzing speech during intoxication may present a more direct, objective measure, offering a unique 'window' into the mind. Here, we employed computational analyses of speech semantic and topological structure after +/-3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') and methamphetamine in 13 ecstasy users. In 4 sessions, participants completed a 10-min speech task after MDMA (0.75 and 1.5 mg/kg), methamphetamine (20 mg), or placebo. Latent Semantic Analyses identified the semantic proximity between speech content and concepts relevant to drug effects. Graph-based analyses identified topological speech characteristics. Group-level drug effects on semantic distances and topology were assessed. Machine-learning analyses (with leave-one-out cross-validation) assessed whether speech characteristics could predict drug condition in the individual subject. Speech after MDMA (1.5 mg/kg) had greater semantic proximity than placebo to the concepts friend, support, intimacy, and rapport. Speech on MDMA (0.75 mg/kg) had greater proximity to empathy than placebo. Conversely, speech on methamphetamine was further from compassion than placebo. Classifiers discriminated between MDMA (1.5 mg/kg) and placebo with 88% accuracy, and MDMA (1.5 mg/kg) and methamphetamine with 84% accuracy. For the two MDMA doses, the classifier performed at chance. These data suggest that automated semantic speech analyses can capture subtle alterations in mental state, accurately discriminating between drugs. The findings also illustrate the potential for automated speech-based approaches to characterize clinically relevant alterations to mental state, including those occurring in psychiatric illness. FAU - Bedi, Gillinder AU - Bedi G AD - 1] Division on Substance Abuse, New York State Psychiatric Institute, and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA [2] Human Behavioral Pharmacology Laboratory, Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA. FAU - Cecchi, Guillermo A AU - Cecchi GA AD - Computational Biology Center-Neuroscience, IBM T.J. Watson Research Center, Yorktown Heights, NY, USA. FAU - Slezak, Diego F AU - Slezak DF AD - Computer Science Department, School of Sciences, Universidad de Buenos Aires, Buenos Aires, Argentina. FAU - Carrillo, Facundo AU - Carrillo F AD - Computer Science Department, School of Sciences, Universidad de Buenos Aires, Buenos Aires, Argentina. FAU - Sigman, Mariano AU - Sigman M AD - Physics Department, School of Sciences, Universidad de Buenos Aires, Buenos Aires, Argentina. FAU - de Wit, Harriet AU - de Wit H AD - Human Behavioral Pharmacology Laboratory, Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA. LA - eng GR - UL1 TR000430/TR/NCATS NIH HHS/United States GR - DA02812/DA/NIDA NIH HHS/United States GR - R21 DA026570/DA/NIDA NIH HHS/United States GR - K23 DA034877/DA/NIDA NIH HHS/United States GR - R01 DA002812/DA/NIDA NIH HHS/United States GR - R03 DA029679/DA/NIDA NIH HHS/United States GR - DA029679/DA/NIDA NIH HHS/United States GR - DA026570/DA/NIDA NIH HHS/United States GR - DA034877/DA/NIDA NIH HHS/United States PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural DEP - 20140403 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Illicit Drugs) RN - 0 (Psychotropic Drugs) RN - 44RAL3456C (Methamphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adolescent MH - Adult MH - Artificial Intelligence MH - Double-Blind Method MH - Female MH - Humans MH - Illicit Drugs MH - Male MH - Mental Processes/drug effects MH - Methamphetamine/*administration & dosage MH - N-Methyl-3,4-methylenedioxyamphetamine/*administration & dosage MH - Pattern Recognition, Automated MH - Psychotropic Drugs/*administration & dosage MH - *Semantics MH - Speech/*drug effects MH - Substance-Related Disorders/*psychology MH - Young Adult PMC - PMC4138742 EDAT- 2014/04/04 06:00 MHDA- 2015/04/16 06:00 PMCR- 2015/09/01 CRDT- 2014/04/04 06:00 PHST- 2013/09/08 00:00 [received] PHST- 2014/01/20 00:00 [revised] PHST- 2014/03/24 00:00 [accepted] PHST- 2014/04/04 06:00 [entrez] PHST- 2014/04/04 06:00 [pubmed] PHST- 2015/04/16 06:00 [medline] PHST- 2015/09/01 00:00 [pmc-release] AID - npp201480 [pii] AID - 10.1038/npp.2014.80 [doi] PST - ppublish SO - Neuropsychopharmacology. 2014 Sep;39(10):2340-8. doi: 10.1038/npp.2014.80. Epub 2014 Apr 3.